Market Research Logo

Tumor Ablation Market by Technology (Radiofrequency, Microwave, Cryoablation, IRE, Ultrasound), Mode of treatment (Surgical, Laparoscopic, Percutaneous), Application (Liver, Lung, Kidney, Bone Metastasis, Prostate, Breast) - Global Forecasts to 2020

Tumor Ablation Market by Technology (Radiofrequency, Microwave, Cryoablation, IRE, Ultrasound), Mode of treatment (Surgical, Laparoscopic, Percutaneous), Application (Liver, Lung, Kidney, Bone Metastasis, Prostate, Breast) - Global Forecasts to 2020

The global tumor ablation market is poised to grow at a CAGR of 11.5% during the forecast period (2015-2020), and is expected to reach a value of ~515.2 million by 2020. Although mature markets (such as the U.S., Germany, France, and the U.K.) hold larger shares in the tumor ablation market, the Asia-Pacific region is expected to grow at the highest CAGR in the forecast period. Growth in the tumor ablation market is driven by factors such as growing geriatric population across the world, increasing population base for cancer patients, technological advancements in ablation devices, increasing number of hospitals and surgical and ablation centers, and growing awareness regarding the benefits offered by ablation procedures over those of conventional therapeutic and surgical procedures. However, factors such as cost-containment measures taken by various governments and ongoing healthcare reforms in the U.S. are restraining the growth of this market. In addition, therapeutic challenges related to ablation procedures and stringent regulatory guidelines leading to significant increase in gestation period of product launches are posing significant challenges for the growth of the tumor ablation market.

In this report, the global tumor ablation market is segmented on the basis of technology (radiofrequency ablation, microwave ablation, cryoablation, and other technologies), mode of treatment (surgical, laparoscopic, and percutaneous ablation), and application (liver cancer, lung cancer, kidney cancer, bone metastasis, and other applications). The radiofrequency ablation technology segment accounted for the largest share of the global tumor ablation market in 2014, followed by the microwave ablation technology market. Factors such as significant awareness in the medical community about the application of radiofrequency ablation in cancer treatments, presence of a large number of radiofrequency ablation centers across the globe, and low procedural costs associated with radiofrequency tumor ablation are driving the growth of the radiofrequency tumor ablation market.

Geographically, North America (comprising the U.S. and Canada) commands the largest share of the global tumor ablation market in 2014, followed by Europe. The tumor ablation market in North America is primarily driven by factors such as early introduction and high adoption rate of tumor ablation products in the region, significant trend of replacing older technologies with advanced and innovative therapeutic techniques (such as microwave ablation and cryoablation), and increasing private/public funding to develop and commercialize novel tumor ablation products. However, financial constraints faced by market players are limiting the growth of the tumor ablation market in this region. The Asia-Pacific region is poised to grow at the highest CAGR in the next five years, owing to factors such as large population base paired with high prevalence of various cancers (such as liver, lung, and kidney) in the region, ongoing government initiatives for development and modernization of healthcare infrastructure, increasing adoption due to continuously decreasing prices of tumor ablation products, and rising trends related to localized manufacturing due to growing focus of global giants in the APAC market.

The global tumor ablation market is moderately competitive with various global as well as local market players. As of 2014, the global tumor ablation market was dominated by Medtronic, plc (U.S.), AngioDynamics, Inc. (U.S.), HealthTronics, Inc. (U.S.), Galil Medical, Inc. (U.S.), and Boston Scientific Corporation (U.S.) that together accounted for ~83.0% of the market. New product launches; partnerships, agreements, and collaborations; and strategic acquisitions are the major strategies adopted by most of the market players to achieve growth in the global tumor ablation market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis such as industry analysis (industry trends and Porter’s five force model), market share analysis of top ten players, and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high-growth segments of the tumor ablation market, and high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helped firms garner higher market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on tumor ablation products offered by the top 10 players in the global tumor ablation market. The report analyzes the tumor ablation market by technology, mode of treatment, and application across key geographic regions

Product Development/Innovation: Detailed insights on upcoming tumor ablation technologies, research and development activities, and new product launches in the global tumor ablation market

Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various tumor ablation products across key geographic regions

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global tumor ablation market

Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the global tumor ablation market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
      • MARKETS COVERED
      • GEOGRAPHIC SCOPE
      • YEARS CONSIDERED FOR THE STUDY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • MARKET SIZE ESTIMATION
      • TOP-DOWN APPROACH
      • BOTTOM-UP APPROACH
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • RESEARCH ASSUMPTIONS
  • EXECUTIVE SUMMARY
    • INTRODUCTION
    • CURRENT MARKET SCENARIO
    • FUTURE OUTLOOK
    • CONCLUSION
  • PREMIUM INSIGHTS
    • MARKET OPPORTUNITIES FOR GROWTH IN TUMOR ABLATION MARKET (2015-2020)
    • NORTH AMERICA TO COMMAND THE LARGEST SHARE OF TUMOR ABLATION MARKET FOR ALL MODES OF TREATMENT, IN 2015
    • CHINA AND INDIA TO LEAD THE MARKET GROWTH FOR TUMOR ABLATION TECHNOLOGIES DURING THE FORECAST PERIOD
    • CHINA AND INDIA TO LEAD THE MARKET DEMAND FOR MICROWAVE AND CRYOABLATION-BASED TUMOR ABLATION PRODUCTS
    • LIVER CANCER HOLDS THE LARGEST SHARE IN TUMOR ABLATION MARKET IN 2015
    • MEDTRONIC, PLC DOMINATED THE TUMOR ABLATION MARKET IN 2014
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET SEGMENTATION
      • OVERVIEW
      • IMAPACT ANALYSIS
      • KEY MARKET DRIVERS
      • KEY MARKET RESTRAINTS
      • KEY MARKET OPPORTUNITIES
      • KEY MARKET CHALLENGES
  • INDUSTRY INSIGHTS
    • INTRODUCTION
      • GROWING ADOPTION RATE OF RADIOFREQUENCY-BASED TUMOR ABLATION PROCEDURES
      • GROWING MARKET FOCUS ON THE DEVELOPMENT OF NOVEL MICROWAVE-BASED TUMOR ABLATION PRODUCTS
      • OVERVIEW
      • THREAT FROM NEW ENTRANTS
      • THREAT OF SUBSTITUTES
      • BARGAINING POWER OF SUPPLIERS
      • BARGAINING POWER OF BUYERS
      • INTENSITY OF COMPETITIVE RIVALRY
  • TUMOR ABLATION MARKET, BY TECHNOLOGY
    • INTRODUCTION
      • Table GLOBAL TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
      • Table TUMOR ABLATION MARKET SIZE FOR RF ABLATION TECHNOLOGY, BY REGION, 2013-2020 ($MILLION)
    • RADIOFREQUENCY (RF) ABLATION - KEY INSIGHTS
      • Table TUMOR ABLATION MARKET SIZE FOR MICROWAVE ABLATION TECHNOLOGY, BY REGION, 2013-2020 ($MILLION)
    • MICROWAVE ABLATION - KEY INSIGHTS
      • Table TUMOR ABLATION MARKET SIZE FOR CRYOABLATION TECHNOLOGY, BY REGION, 2013-2020 ($MILLION)
    • CRYOABLATION - KEY INSIGHTS
      • Table TUMOR ABLATION MARKET SIZE FOR OTHER TECHNOLOGIES, BY REGION, 2013-2020 ($MILLION)
    • OTHER TECHNOLOGIES - KEY INSIGHTS
  • TUMOR ABLATION MARKET, BY MODE OF TREATMEN
    • INTRODUCTION
      • Table GLOBAL TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT, 2013-2020 ($MILLION)
      • Table CLINICAL PERSPECTIVE OF KEY HEPATOCELLULAR CARCINOMA SURGICAL TREATMENT MODES - A COMPARATIVE STUDY
      • Table TUMOR ABLATION MARKET SIZE FOR SURGICAL MODE OF TREATMENT, BY REGION, 2013-2020 ($MILLION)
    • SURGICAL ABLATION - KEY INSIGHTS
      • Table TUMOR ABLATION MARKET SIZE FOR LAPAROSCOPIC MODE OF TREATMENT, BY REGION, 2013-2020 ($MILLION)
    • LAPAROSCOPIC ABLATION - KEY INSIGHTS
      • Table TUMOR ABLATION MARKET SIZE FOR PERCUTANEOUS MODE OF TREATMENT, BY REGION, 2013-2020 ($MILLION)
    • PERCUTANEOUS ABLATION - KEY INSIGHTS
      • Table KEY PERCUTANEOUS TUMOR ABLATION TECHNOLOGIES - A COMPARATIVE STUDY
  • TUMOR ABLATION MARKET, BY APPLICATION
    • INTRODUCTION
      • Table GLOBAL TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2013-2020($MILLION)
      • Table TUMOR ABLATION MARKET SIZE FOR LIVER CANCER APPLICATION, BY REGION, 2013-2020 ($MILLION)
      • LIVER CANCER ABLATION - KEY INSIGHTS
        • Table LIVER CANCER ABLATION MARKET-INFLUENCING FACTORS
        • Table TUMOR ABLATION MARKET SIZE FOR LUNG CANCER APPLICATION, BY REGION, 2013-2020 ($MILLION)
      • LUNG CANCER ABLATION - KEY INSIGHTS
        • Table LUNG CANCER ABLATION MARKET-INFLUENCING FACTORS
        • Table TUMOR ABLATION MARKET SIZE FOR KIDNEY CANCER APPLICATION, BY REGION, 2013-2020 ($MILLION)
      • KIDNEY CANCER ABLATION - KEY INSIGHTS
        • Table KIDNEY CANCER ABLATION MARKET-INFLUENCING FACTORS
        • Table TUMOR ABLATION MARKET SIZE FOR BONE METASTASIS APPLICATION, BY REGION, 2013-2020 ($MILLION)
      • BONE METASTASIS ABLATION - KEY INSIGHTS
        • Table BONE METASTASIS ABLATION MARKET-INFLUENCING FACTORS
        • Table TUMOR ABLATION MARKET SIZE FOR OTHER APPLICATIONS, BY REGION, 2013-2020 ($MILLION)
      • OTHER APPLICATIONS - KEY INSIGHTS
  • TUMOR ABLATION MARKET, BY REGION
    • INTRODUCTION
      • Table GLOBAL TUMOR ABLATION MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
      • Table NORTH AMERICA: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
      • Table NORTH AMERICA: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT, 2013-2020 ($MILLION)
      • Table NORTH AMERICA: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
      • U.S.
        • Table U.S.: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
        • Table U.S.: TUMOR ABLATION MARKET SHARE, BY MODE OF TREATMENT (2015)
        • Table U.S.: TUMOR ABLATION MARKET SHARE, BY APPLICATION (2015)
      • CANADA
        • Table CANADA: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
        • Table CANADA: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT, 2013-2020 ($MILLION)
        • Table CANADA: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
    • EUROPE
      • Table EUROPE: TUMOR ABLATION MARKET SIZE, BY COUNTRY/REGION, 2013-2020 ($MILLION)
      • Table EUROPE: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
      • Table EUROPE: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT, 2013-2020 ($MILLION)
      • Table EUROPE: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
      • ITALY
        • Table ITALY: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
        • Table ITALY: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT, 2013-2020 ($MILLION)
        • Table ITALY: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
      • GERMANY
        • Table GERMANY: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
        • Table GERMANY: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT, 2013-2020 ($MILLION)
        • Table GERMANY: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
      • FRANCE
        • Table FRANCE: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
        • Table FRANCE: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT, 2013-2020 ($MILLION)
        • Table FRANCE: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
      • U.K.
        • Table U.K.: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
        • Table U.K.: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT, 2013-2020 ($MILLION)
        • Table U.K.: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
      • SPAIN
        • Table SPAIN: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
        • Table SPAIN: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT, 2013-2020 ($MILLION)
        • Table SPAIN: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
      • REST OF EUROPE (RoE)
        • Table ROE: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
        • Table ROE: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT, 2013-2020 ($MILLION)
        • Table ROE: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
    • ASIA-PACIFIC
      • Table ASIA-PACIFIC: TUMOR ABLATION MARKET SIZE, BY COUNTRY/REGION, 2013-2020 ($MILLION)
      • Table ASIA-PACIFIC: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
      • Table ASIA-PACIFIC: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT, 2013-2020 ($MILLION)
      • JAPAN
        • Table JAPAN: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
        • Table JAPAN: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT, 2013-2020 ($MILLION)
        • Table JAPAN: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
      • CHINA
        • Table CHINA: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
        • Table CHINA: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT, 2013-2020 ($MILLION)
        • Table CHINA: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
      • INDIA
        • Table INDIA: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
        • Table INDIA: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT, 2013-2020 ($MILLION)
        • Table INDIA: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
      • REST OF ASIA-PACIFIC (RoAPAC)
        • Table ROAPAC: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
        • Table ROAPAC: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT, 2013-2020 ($MILLION)
        • Table ROAPAC: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
    • REST OF THE WORLD (RoW)
      • Table ROW: TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION)
      • Table ROW: TUMOR ABLATION MARKET SIZE, BY MODE OF TREATMENT, 2013-2020 ($MILLION)
      • Table ROW: TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • COMPETITIVE LANDSCAPE
    • INTRODUCTION
    • MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014
    • COMPETITIVE SCENARIO
    • RECENT DEVELOPMENTS
      • PIPELINE DEVELOPMENTS AND PRODUCT ENHANCEMENTS
        • Table PIPELINE DEVELOPMENTS AND PRODUCT ENHANCEMENTS (2012-2015)
      • DIVESTMENTS AND ACQUISITIONS
        • Table DIVESTMENTS AND ACQUISITIONS (2012-2015)
      • GEOGRAPHIC EXPANSION
        • Table GEOGRAPHIC EXPANSIONS (2012-2015)
      • AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
        • Table AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS (2012-2015)
      • OTHER DEVELOPMENTS
        • Table Other Developments (2012-2015)
  • COMPANY PROFILES
    • INTRODUCTION
      • GEOGRAPHIC BENCHMARKING
      • KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS
    • MEDTRONIC PLC (U.S.)
      • COMPANY OVERVIEW
      • MNM VIEW
      • MEDTRONIC PLC - COMPANY SNAPSHOT
      • PRODUCT PORTFOLIO
      • RECENT DEVELOPMENTS (2012-2015)
    • ANGIODYNAMICS, INC. (U.S.)
      • COMPANY OVERVIEW
      • MNM VIEW
      • ANGIODYNAMICS, INC. - COMPANY SNAPSHOT
      • PRODUCT PORTFOLIO
      • RECENT DEVELOPMENTS (2012-2015)
    • HEALTHTRONICS, INC. (U.S.) (A BUSINESS SEGMENT OF ENDO INTERNATIONAL PLC., IRELAND)
      • COMPANY OVERVIEW
      • MNM VIEW
      • ENDO INTERNATIONAL PLC - COMPANY SNAPSHOT
      • PRODUCT PORTFOLIO
      • RECENT DEVELOPMENTS (2012-2015)
    • GALIL MEDICAL, INC. (U.S.)
      • COMPANY OVERVIEW
      • MNM VIEW
      • PRODUCT PORTFOLIO
      • RECENT DEVELOPMENTS (2012-2015)
    • BOSTON SCIENTIFIC CORPORATION (U.S)
      • COMPANY OVERVIEW
      • MNM VIEW
      • BOSTON SCIENTIFIC CORPORATION - COMPANY SNAPSHOT
      • PRODUCT PORTFOLIO
      • RECENT DEVELOPMENTS (2012-2015)
    • NEUWAVE MEDICAL, INC. (U.S)
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • RECENT DEVELOPMENTS (2012-2015)
    • EDAP TMS S.A. (FRANCE)
      • COMPANY OVERVIEW
      • EDA TMS S.A. - COMPANY SNAPSHOT*
      • PRODUCT PORTFOLIO
      • RECENT DEVELOPMENTS (2012-2015)
    • MERMAID MEDICAL, INC. (DENMARK)
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • RECENT DEVELOPMENTS (2012-2015)
    • SONACARE MEDICAL, LLC (U.S)
      • COMPANY OVERVIEW
      • PRODUCT PORTFOLIO
      • RECENT DEVELOPMENTS (2012-2015)
    • MISONIX, INC. (U.S)
      • COMPANY OVERVIEW
      • MISONIX, INC. - COMPANY SNAPSHOT
      • PRODUCT PORTFOLIO
      • RECENT DEVELOPMENTS (2012-2015)
  • APPENDIX
    • INSIGHTS FROM INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report